Department of Paediatric Cardiology, University of Leipzig, Heart Centre, Leipzig, Germany.
Br J Pharmacol. 2009 Sep;158(1):198-208. doi: 10.1111/j.1476-5381.2009.00344.x.
In mammalian heart, connexin43 (Cx43) represents the predominant connexin in the working myocardium. As the beta-adrenoceptor is involved in many cardiac diseases, we wanted to clarify the pathway by which beta-adrenoceptor stimulation may control Cx43 expression.
Cultured neonatal rat cardiomyocytes were stimulated with isoprenaline. Cx43 expression as well as activation of p38 mitogen-activated protein kinase (MAPK), p42/44 MAPK, JUN NH(2)-terminal kinase (JNK) and nuclear translocation of the transcription factors activator protein 1 (AP1) and CRE-binding protein (CREB) were investigated. Additionally, we assessed Cx43 expression and distribution in left ventricular biopsies from patients without any significant heart disease, and from patients with either congestive heart failure [dilated cardiomyopathy (DCM)] or hypertrophic cardiomyopathy (HCM).
Isoprenaline exposure caused about twofold up-regulation of Cx43 protein with a pEC(50) of 7.92 +/- 0.11, which was inhibited by propranolol, SB203580 (4-(4-fluorophenyl)-2-(4-methylsulphinylphenyl)-5-(4-pyridyl)-1H-imidazole) (p38 inhibitor), PD98059 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one) (MAPK 1 kinase inhibitor) (Alexis Biochemicals, San Diego, CA, USA) or cyclosporin A. Similar findings were obtained for Cx43 mRNA. Furthermore, Cx43 up-regulation was accompanied by phosphorylation of p38, p42/44 and JNK, and by translocation of AP1 and CREB to the nucleus. Analysis of Cx43 protein and mRNA in ventricular biopsies revealed that in patients with DCM, Cx43 content was significantly lower, and in patients with HCM, Cx43 content was significantly higher, relative to patients without any cardiomyopathy. More importantly, Cx43 distribution also changed with more Cx43 being localized at the lateral border of the cardiomyocytes.
Beta-adrenoceptor stimulation up-regulated cardiac Cx43 expression via a protein kinase A and MAPK-regulated pathway, possibly involving AP1 and CREB. Cardiomyopathy altered Cx43 expression and distribution.
在哺乳动物心脏中,连接蛋白 43(Cx43)是工作心肌中主要的连接蛋白。由于β-肾上腺素能受体参与许多心脏疾病,我们希望阐明β-肾上腺素能受体刺激可能控制 Cx43 表达的途径。
用异丙肾上腺素刺激培养的新生大鼠心肌细胞。研究了 Cx43 表达以及 p38 丝裂原活化蛋白激酶(MAPK)、p42/44 MAPK、JUN NH(2)-末端激酶(JNK)和转录因子激活蛋白 1(AP1)和 CRE 结合蛋白(CREB)的核转位。此外,我们评估了来自没有明显心脏病的患者以及充血性心力衰竭[扩张型心肌病(DCM)]或肥厚型心肌病(HCM)患者的左心室活检中的 Cx43 表达和分布。
异丙肾上腺素暴露导致 Cx43 蛋白上调约 2 倍,pEC(50)为 7.92 +/- 0.11,被心得安、SB203580(4-(4-氟苯基)-2-(4-甲磺酰基苯基)-5-(4-吡啶基)-1H-咪唑)(p38 抑制剂)、PD98059 2-(2-氨基-3-甲氧基苯基)-4H-1-苯并吡喃-4-酮)(MAPK 1 激酶抑制剂)(Alexis Biochemicals,圣地亚哥,CA,美国)或环孢素 A 抑制。Cx43 mRNA 也有类似的发现。此外,Cx43 上调伴随着 p38、p42/44 和 JNK 的磷酸化,以及 AP1 和 CREB 向核内易位。对心室活检中的 Cx43 蛋白和 mRNA 的分析表明,在 DCM 患者中,Cx43 含量明显降低,在 HCM 患者中,Cx43 含量明显升高,与没有心肌病的患者相比。更重要的是,Cx43 的分布也发生了变化,更多的 Cx43 定位于心肌细胞的侧边界。
β-肾上腺素能受体刺激通过蛋白激酶 A 和 MAPK 调节的途径上调心脏 Cx43 表达,可能涉及 AP1 和 CREB。心肌病改变了 Cx43 的表达和分布。